Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection
Authors
Keywords
-
Journal
Vaccines
Volume 10, Issue 8, Pages 1210
Publisher
MDPI AG
Online
2022-08-02
DOI
10.3390/vaccines10081210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
- (2022) Ariel Israel et al. Vaccines
- SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
- (2022) Li Guo et al. Lancet Microbe
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection
- (2021) Hao Wang et al. Cellular & Molecular Immunology
- Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose
- (2021) Ilaria Vicenti et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG
- (2021) Amedeo F. Capetti et al. JOURNAL OF INFECTION
- Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
- (2021) Madhumita Shrotri et al. LANCET
- SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
- (2021) Jackson S. Turner et al. NATURE
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
- (2021) Ugur Sahin et al. NATURE
- Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
- (2021) Cesheng Li et al. Nature Communications
- Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays
- (2021) Andrea Padoan et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Dynamics of IgG-avidity and antibody levels after Covid-19
- (2021) Emma Löfström et al. JOURNAL OF CLINICAL VIROLOGY
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
- (2021) Rishi R. Goel et al. SCIENCE
- Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for Accurate and Prompt Coronavirus Disease 2019 (COVID-19) Diagnosis Using the Rational Selection of Serological Biomarkers
- (2021) Theano Lagousi et al. Diagnostics
- Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals
- (2021) Evangelos Terpos et al. Life-Basel
- Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
- (2021) Deborah Cromer et al. Lancet Microbe
- Lessons for COVID-19 Immunity from Other Coronavirus Infections
- (2020) Alan Sariol et al. IMMUNITY
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started